These effects depend on the type, route of administration, dose, and duration of action of each specific GLP-1 receptor agonist, as well as individual characteristics such as baseline body weight and degree of glucose tolerance
Furthermore, this approach enables the identification of previously unrecognized or population-specific adverse events through comparative analysis across subgroups, contributing to more comprehensive drug safety profiling
Schernhammer ES, Berrino F, Krogh V, et al
Hsiao, S.-C
This work was partially supported by National Natural Science Foundation of China 81872915 (M.-W.W.), 82073904 (M.-W.W.), 81922071 (Y.Z.), 81773792 (D.Y.), 81973373 (D.Y.) and 21704064 (Q.Z.)
Ask Your Clinician if a GLP-1 May Be Right for You GLP-1 medications have changed the landscape of care for people navigating type 2 diabetes and weight loss